PPARG and acute promyelocytic leukemia: Also, we evaluated differentiation associated CEBPE, PPARG, CSF3R, and CSF3 genes expression changes after NB4, HL60, and APL patient blasts' treatment with different combinations of 3-Deazaneplanocin A, Belinostat, Idarubicin, and Retinoic acid for 6 hours and for 72 hours (Figure 3(b)).